Lupin gains as its arm launches first Reference Laboratory in Ranchi
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Lupin is currently trading at Rs. 645.70, up by 2.40 points or 0.37% from its previous closing of Rs. 643.30 on the BSE.
The scrip opened at Rs. 645.25 and has touched a high and low of Rs. 647.50 and Rs. 643.45 respectively. So far 3417 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1193.00 on 20-Jul-2021 and a 52 week low of Rs. 583.05 on 25-May-2022.
Last one week high and low of the scrip stood at Rs. 654.20 and Rs. 636.90 respectively. The current market cap of the company is Rs. 29245.92 crore.
The promoters holding in the company stood at 47.10%, while Institutions and Non-Institutions held 41.45% and 11.45% respectively.
Lupin’s subsidiary -- Lupin Diagnostics has launched its first Reference Laboratory in Ranchi. The new Reference Laboratory at Ranchi is equipped to conduct a broad spectrum of routine and specialized tests in the fields of molecular diagnostics, cytogenetics, flow cytometry, histopathology, cytology, microbiology, serology, haematology, immunology, and routine biochemistry.
Lupin Diagnostics will equip doctors with accurate diagnosis in the patient journey by leveraging innovative technologies for improved patient care. People in Jharkhand can now avail preventive health check-ups, home collection and testing centers at 10 locations.
Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.
